A phase lb study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

被引：1
|
作者：
Weekes, Colin
Lockhart, A. Craig
Lenz, Heinz-Josef
Lee, James J.
Cleton, Adriaan
Huang, Funan
Sturm, Isrid
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-CT148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT148
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
    Cascone, T.
    Sacks, R. L.
    Subbiah, I. M.
    Drobnitzky, N.
    Piha-Paul, S. A.
    Hong, D. S.
    Hess, K. R.
    Amini, B.
    Bhatt, T.
    Fu, S.
    Naing, A.
    Janku, F.
    Karp, D.
    Falchook, G. S.
    Conley, A. P.
    Sherman, S., I
    Meric-Bernstam, F.
    Ryan, A. J.
    Heymach, J., V
    Subbiah, V
    ESMO OPEN, 2021, 6 (02)
  • [32] A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors
    Albanell, Joan
    Montagut, Clara
    Jones, Eileen T.
    Pronk, Linda
    Mellado, Begona
    Beech, Janette
    Gascon, Pere
    Zugmaier, Gerhard
    Brewster, Michael
    Saunders, Mark P.
    Valle, Juan W.
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2726 - 2731
  • [33] Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics (vol 32, pg 104, 2014)
    Sunakawa, Yu
    Furuse, Junji
    Okusaka, Takuji
    Ikeda, Masafumi
    Nagashima, Fumio
    Ueno, Hideki
    Mitsunaga, Shuichi
    Hashizume, Kensei
    Ito, Yuichiro
    Sasaki, Yasutsuna
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 388 - 388
  • [34] A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors
    Goh, Jeffrey
    Gao, Ben
    Markman, Ben
    Gan, Hui
    Voskoboynik, Mark
    Wu, Yi-Long
    Guo, Jun
    Zhou, Qing
    Zhao, Jun
    Chen, Cheng
    Qiu, Jingjun
    Xu, Yingying
    Yang, Liu
    Millward, Michael
    CANCER RESEARCH, 2019, 79 (13)
  • [35] Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I study
    Werner, Theresa L.
    Sachdev, Jasgit
    Swisher, Elizabeth M.
    Gutierrez, Martin
    Kittaneh, Muaiad
    Stein, Mark N.
    Xiong, Hao
    Dunbar, Martin
    Sullivan, Danielle
    Komarnitsky, Philip
    McKee, Mark
    Tan, Antoinette R.
    CANCER MEDICINE, 2018, 7 (06): : 2360 - 2369
  • [36] A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors
    Puglisi, Martina
    Molife, L. Rhoda
    de Jonge, Maja J. A.
    Khan, Khurum H.
    Doorn, Leni van
    Forster, Martin D.
    Blanco, Montserrat
    Gutierrez, Martin
    Franklin, Catherine
    Busman, Todd
    Yang, Jianning
    Eskens, Ferry A. L. M.
    FUTURE ONCOLOGY, 2021, 17 (21) : 2747 - 2758
  • [37] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors
    Poklepovic, Andrew S.
    Gordon, Sarah W.
    Kothadia, Sejal
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Hudson, Daniel
    Bandyopadhyay, Dipankar
    Ryan, Alison A.
    Kmieciak, Maciej
    Smith, Steven
    Dent, Paul
    ANTI-CANCER DRUGS, 2024, 35 (05) : 450 - 458
  • [39] Phase lb study of afatinib plus standard-dose cetuximab in patients with advanced solid tumours
    Gazzah, A.
    Boni, V.
    Soria, J. C.
    Calles, A.
    Even, C.
    Doger, B.
    Mahjoubi, L.
    Bahleda, R.
    Ould-Kaci, M.
    Esler, A.
    Nazabadioko, S.
    Calvo, E.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S139 - S140
  • [40] A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors
    Muindi, Josephia R.
    Johnson, Candace S.
    Trump, Donald L.
    Christy, Renee
    Engler, Kristie L.
    Fakih, Marwan G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 33 - 40
12345